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ATPase activityThe CacyBP/SIP protein interacts with several targets, including actin. Since the majority of actin ﬁlaments are
associated with tropomyosin, in this work we characterized binding of CacyBP/SIP to the actin–tropomyosin
complex and examined the effects of CacyBP/SIP on actin ﬁlament functions. By using reconstituted ﬁlaments
composed of actin and AEDANS-labeled tropomyosin, we observed that binding of CacyBP/SIP caused an
increase in tropomyosin ﬂuorescence intensity indicating the occurrence of conformational changes within
the ﬁlament. We also found that CacyBP/SIP bound directly to tropomyosin and that these proteins did not
compete with each other for binding to actin. Electron microscopy showed that in the absence of tropomyosin
CacyBP/SIP destabilized actin ﬁlaments, but tropomyosin reversed this effect. Actin-activated myosin S1 ATPase
activity assays, performed using a colorimetric method, indicated that CacyBP/SIP reduced ATPase activity and
that the presence of tropomyosin enhanced this inhibitory effect. Thus, our results suggest that CacyBP/SIP,
through its interaction with both actin and tropomyosin, regulates the organization and functional properties
of the thin ﬁlament.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Multiple cellular functions depend on the interaction of actin, inmo-
nomeric or ﬁlamentous forms, with panoply of actin-binding proteins.
Among them are myosin motors, proteins affecting actin conformation
(gelsolin, coﬁlin, thymosin β4, capping protein), proteins involved in
ﬁlament nucleation and elongation (Arp2/3, VASP, formins), proteins
anchoringﬁlaments to plasmamembrane (ezrin, talin, vinculin) and in-
volved in the supramolecular organization of actin ﬁlaments (α-actinin,
ﬁlamin, fascin, villin and tropomyosin) [1]. The central regulator that
stabilizes the actin ﬁlament and controls the access of actin-binding
partners is tropomyosin, a two-chain coiled-coiled protein, which poly-
merizes along both sides of the actin ﬁlament [2]. The mechanism of
actin ﬁlament regulation by tropomyosin was ﬁrst described in muscle,
where tropomyosin was found to act as a steric/allosteric regulator ofyBP/SIP, Calcyclin (S100A6)
hiothreitol; EDC, 1-ethyl-3-(3-
odoacetyl)amino)ethyl)amino)-
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rights reserved.the thin ﬁlament [3]. At present, a growing number of evidence shows
that tropomyosin-dependent regulation of the thin ﬁlament in non-
muscle cells is at the cross-roads of different processes [2].
CacyBP/SIPwas originally discovered as a ligand of S100A6 (calcyclin)
[4] and then as a binding partner of Siah-1 [5]. CacyBP/SIP is composed of
three domains, one of which is homologous to the SGS (Sgt1 speciﬁc)
domain of the Sgt1 protein [6]. Up to now, a lot of work was performed
to establish the properties and function of CacyBP/SIP but the biological
importance of this protein still remains unclear [6]. Quite recently we
have shown that CacyBP/SIP binds both to monomeric and ﬁlamentous
actin [7]. Interaction of CacyBP/SIP with actin suggests its involvement
in organization of the cytoskeleton which undergoes dynamic re-
arrangements, especially important during development, aging or in
neurodegeneration. Indeed, it has been shown that CacyBP/SIP has an
effect on differentiation of neuroblastoma NB2a cells [8] or on neuronal
cytoskeleton organization during aging [9].
SinceCacyBP/SIP has been shown to bind to actin [7] and themajority
of actin ﬁlaments are associatedwith tropomyosin, in this workwe have
examined the effects of CacyBP/SIP on actin–tropomyosin interaction.
For that we prepared ﬁlaments reconstituted from actin and AEDANS-
labeled tropomyosin andmonitoredﬂuorescence changes upon addition
of CacyBP/SIP. Since we have observed an increase in ﬂuorescence
intensity we then tested themechanisms leading to the conformational
changes occurring after the addition of CacyBP/SIP.Moreover,we exam-
ined the structural and functional effects of CacyBP/SIP on the thin
ﬁlament organization by electron microscopy and by measuring the
acto-myosin Mg-ATPase activity.
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2.1. Protein puriﬁcation
Actin was isolated from chicken pectoral muscle acetone powder
according to Spudich and Watt [10]. It was stored in the form of
G-actin in a buffer containing 2 mM HEPES, pH 7.6, 0.2 mM ATP,
0.1 mM CaCl2, 0.2 mM DTT and 0.02% NaN3 (G-buffer).
Rat fast skeletal muscleαα-tropomyosin (referred to as tropomyosin
throughout the text) was expressed in BL21 (DE3) cells [11] and puriﬁed
as described before [12]. Bacterially expressed recombinant tropomyosin
lacks N-terminal acetylation, which reduces its afﬁnity for actin. In
order to compensate for this defect, an Ala-Ser N-terminal extension,
which mimics the acetyl group, is commonly added [13]. For that cDNA
encoding α-tropomyosin was modiﬁed by insertion of Met–Ala–Ser
codons at the 5′-end using PCR-based oligonucleotide-directed
mutagenesis (Stratagene) as described by Robaszkiewicz et al. [14].
All steps of recombinant CacyBP/SIP expression and puriﬁcation
were performed as described earlier [7,15]. Puriﬁed CacyBP/SIP was
dialyzed against buffer containing 20 mM Tris pH 7.5 and 150 mM
NaCl and centrifuged for 45 min at 200,000 ×g at 4 °C. Protein from
the supernatant fraction was used in further experiments.
Myosin subfragment 1 (S1) was prepared by papain digestion of
chicken pectoral muscle myosin using the method described by
Margossian and Lowy [16]. The concentration of actin was deter-
mined spectrophotometrically using an extinction coefﬁcient of 0.63
for 0.1% actin at 290 nm andMW42,000. The concentration of recom-
binant tropomyosin was estimated by differential absorption spectra
of the tyrosine residue [12]. The concentration of S1 was estimated
from an extinction coefﬁcient of 0.83 for 0.1% protein at 280 nm
and MW 130,000. The concentration of recombinant CacyBP/SIP was
measured according to Bradford's procedure.
2.2. Protein labeling
The single cysteine residue at position 190 in each chain of tropo-
myosin was labeled with 1,5-IAEDANS as described previously [17]
with the following modiﬁcations. Tropomyosin at concentration of
about 60 μM was incubated at 54 °C for 4 min with 1 mM DTT. The
reduced protein was dialyzed exhaustively to F-buffer (20 mM Tris,
pH 7.5, 150 mM NaCl, 2 mMMgCl2). Tropomyosin dimer was dissoci-
ated in 4 M guanidine-HCl and labeled with a 20-fold molar excess of
1,5-IAEDANS for 24 h in 37 °C. The reaction was terminated by the
addition of a 2-fold molar excess of DTT over IAEDANS, followed by
exhaustive dialysis against F-buffer. The labeling ratio was calculated
from the extinction coefﬁcient of 6,100 M−1 cm−1 at 337 nm. In all
preparations the molar ratio of AEDANS to tropomyosin dimer was
2:1.
2.3. Fluorescence measurements
The steady-state ﬂuorescence was measured with an Aminco
Bowman series 2 luminescence spectrometer. Sample cuvettes were
thermostated at 22 °C. The excitation wavelength was set at 340 nm,
emission was measured at a single wavelength of 495 nm. Actin was
polymerized as in the co-sedimentation experiments (see below).
Fluorescence measurements were done in F-buffer with 0.4 μM
AEDANS-labeled tropomyosin, 3.0 μM F-actin and CacyBP/SIP at con-
centrations varying from 1 to 24 μM (corresponding to 0.3–8 CacyBP/
SIP:F-actin molar ratio). Fluorescence intensity obtained at each exper-
imental point was normalized as follows:
y ¼ F−F0ð Þ= Fmax−F0ð Þ
where F is the value of the ﬂuorescence at a given CacyBP/SIP concen-
tration, F0 — the value of the ﬂuorescence obtained in the absence ofCacyBP/SIP, Fmax — maximal ﬂuorescence (obtained by ﬁtting the
crude experimental data to the ligand-binding equation). The curve
between points was drawn by ﬁtting the normalized points to the
ligand-binding equation in DataWnd software (property of A.A.
Kasprzak, Nencki Institute of Experimental Biology, Warsaw, Poland).
2.4. Co-sedimentation assay
Binding of CacyBP/SIP to the actin–tropomyosin complex was
studied by co-sedimentation. Before the assay, tropomyosin and
CacyBP/SIP were independently ultracentrifuged at 172,000 ×g. The
tightly bound Ca2+ in G-actin was replaced with Mg2+ prior to poly-
merization by 10-min incubation at RT with 0.2 mM EGTA and
0.1 mMMgCl2. The resulting Mg-G-actin was polymerized by incuba-
tion with 2 mM MgCl2 and 150 mM NaCl for 20 min at RT. The assay
samples were composed of 3.0 μM Mg-F-actin, 0.4 μM AEDANS–
tropomyosin and CacyBP/SIP at concentrations varying from 1 to 24
μM (corresponding to 0.3–8.0 CacyBP/SIP:F-actin molar ratio) in buff-
er containing 20 mM Tris, pH, 7.0, 2 mM MgCl2 and 150 mM NaCl.
Protein mixtures were ultracentrifuged for 1 h at 200,000 ×g. The
protein composition of the pellets was examined by 10% SDS-PAGE.
The gels were stained with Coomassie brilliant blue G250, the protein
bands were scanned with Plustek OpticPro ST12 and their density
was quantitated using the EasyDens software (Cortex Nova, Byd-
goszcz, Poland). The experimental data were normalized as described
in Section 2.3. The binding curve was drawn by ﬁtting the normalized
points to Hill equation [12,14].
2.5. ATPase activity assay
The ATPase activity assay was carried out in 96-well microtiter
plates at 22 °C. Actin, myosin S1, and tropomyosin were kept at con-
stant 4 μM, 4 μM, and 2 μM concentrations, respectively, whereas
CacyBP/SIP concentration varied between 0 and 22 μM. The conditions
were: 40 mM NaCl, 5 mM MgCl2, 1 mM DTT and 10 mM Tris–HCl, pH
7.0. The reactionwas initiated by addingMg-ATP to the ﬁnal concentra-
tion 5 mM and terminated after 10 min by adding SDS and EDTA to
ﬁnal concentrations of 3.3% and 30 mM, respectively. The amount of
inorganic phosphate released was determined colorimetrically [18].
2.6. Afﬁnity chromatography
The coupling of puriﬁed recombinant CacyBP/SIP protein to CNBr-
Sepharose (GE Healthcare) was carried out according to the procedure
outlined by themanufacturer. A resin with no coupled proteinwas pre-
pared at the same time.
At ﬁrst, tropomyosin was applied to the resin with no coupled
protein (to eliminate the non-speciﬁc binding) and then the un-
bound fraction was applied to CacyBP/SIP afﬁnity resin in the buffer
containing 10 mM Tris, pH 7.5, 1 mM DTT and 150 mM NaCl. The
resin was extensively washed with the above buffer and then the
bound protein was eluted with the buffer containing 500 mM NaCl.
Collected fractions were precipitated with acetone and analyzed by
Western blot technique using mouse monoclonal anti-tropomyosin
antibody diluted 1:1000 (Sigma, T2780).
2.7. Cell culture and immunoﬂuorescence staining
Mouse C2C12 myoblast cells were grown in Dulbecco's modiﬁed
Eagle's medium (DMEM; Sigma) containing 1% L-glutamine (Sigma),
10% fetal bovine serum(Gibco), penicillin (100 U/ml) and streptomycin
(0.1 mg/ml) (Sigma) in 5% CO2 at 37 °C. For myogenic differentiation,
cells were cultured in low serum containing myogenic differentiation
media (DMEM, 1% L-glutamine, 2% heat-inactivated horse serum, 1%
PS) for 5 days with media renewal every 48 h.
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and differentiated myotubes. C2C12 cells were cultured on glass
cover slips, previously coated with poly-L-lysine (50 μg/ml), for
24 h (undifferentiated cells) and 5 days (myotubes). Cells were
ﬁxed with 3% paraformaldehyde in ICCH buffer (120 mM PIPES,
50 mM HEPES, 20 mM EGTA, 8 mM MgCl2, pH 6.9) for 20 min at
RT. The coverslips were then treated with 50 mM NH4Cl, for
10 min, to reduce aldehyde groups and then the cells were perme-
abilized for 4 min, at 4 °C with 0.1% Triton X-100 in ICCH buffer. In
the next step cells were incubated in PBS buffer containing 3% of
BSA for 1 h and subsequently stained for 2 h at RT with anti-
CacyBP/SIP serum (1:500) in 1% BSA in PBS buffer. The reaction with
secondary antibodies was carried out at RT for 1 h, using Alexa Fluor
488 (1:1000). To visualize tropomyosin, cells were incubated overnight
at 4 °C with monoclonal anti-tropomyosin antibody (Sigma) diluted
1:400 and then for 1 h at RT with secondary donkey anti-mouse anti-
bodies conjugated with Alexa Fluor 555 (Molecular Probes) diluted
1:1000 in 1%BSA in PBS buffer. All steps described abovewere preceded
by intensive washes in PBS. After washing with PBS and subsequently
with water, cover slips were mounted on slides with VectoShield
with DAPI (Vector Laboratories). Immunoﬂuorescence staining was
observed under a Leica microscope (TCS SP5).
2.8. Transmission electron microscopy
Prior to the experiment, CacyBP/SIP and tropomyosin were dia-
lyzed against a buffer containing 10 mM Tris pH 7.2 and 150 mM
NaCl and then centrifuged for 45 min at 200,000 ×g at 4 °C. Tropomy-
osin at 1 μM ﬁnal concentration was incubated in a buffer containing
10 mM Tris pH 7.2, 2 mM MgCl2, 150 mM NaCl with F-actin (2 μM
ﬁnal concentration) in the absence or presence of 10 μM CacyBP/SIP
for 30 min at 37 °C. Copper grids, covered with parlodion (SPI Sup-
plies) and carbon, were used. 10 μl of samples were applied to a
grid for 40 s. Negative staining was performed with 2% aqueous solu-
tion of uranyl acetate for 25 s. The grids were observed under the
JEOL-1200EX electron microscope.
2.9. Estimation of Kd value
Binding of tropomyosin to CacyBP/SIP and dissociation constant
(Kd), were assessed by means of quartz crystal microbalance (QCM-D)
as described in [19]. All QCM-Dmeasurements were performed in a liq-
uid ﬂow cell setup which allows introducing a ~40 μl sample volume at
a time. AT-cut piezoelectric quartz crystal sensors with gold electrodes
deposited on both sides with 5 MHz fundamental resonant frequency
(QSX 301, Qsense, Sweden) were used. A clean sensor was mounted
in the measuring chamber enabling only one gold electrode to be in
contact with the solution. The study was carried out in 20 mM Tris–
HCl buffer (pH 7.5) supplemented with 150 mM NaCl and 2 mM
MgCl2 at RT. Teﬂon tubing allowed liquid delivery and exchange with
a ﬂow rate 200 μl/min. CacyBP/SIP at 1.0 μM concentration was intro-
duced into the system for 20 min, allowing the molecules to ﬁrmly at-
tach to the surface via sulfur-gold covalent bond (from the cysteine
residues in the protein structure). Next, the sensor was thoroughly
rinsed with the above buffer in order to remove unattached molecules.
The protein-functionalized sensor was then incubated with 2 mg/ml of
bovine serumalbumin (BSA) for 10 min in order to block the remaining
free Au-surface. Then tropomyosin was added at concentrations from
0.1 up to 1.5 μM. All data were modeled using the QTools graphing
and modeling software from Qsense, Sweden.
2.10. Cross-linking experiments
Tropomyosin (10 μM) was mixed with CacyBP/SIP (30 μM) in 15 μl
of a buffer containing 2 mM HEPES, pH 7.6, 0.5 mM ATP and 0.2 mM
CaCl2. The zero-length cross-linking reagent, EDC (Sigma), was addedfrom fresh stocks to 2.5 mM ﬁnal concentration. In control reactions,
CacyBP/SIP and tropomyosin were cross-linked separately or were in-
cubated without the cross-linker. After 1 h incubation at 25 °C, the re-
action was terminated by addition of DTT to a ﬁnal concentration of
11 mM. Half of the reaction mixture was analyzed by 10% SDS-PAGE
stained with Coomassie brilliant blue R250.
2.11. SDS-PAGE and Western blotting
Gel electrophoresis with 10% (w/v) polyacrylamide containing
0.1% SDS was performed by the method of Laemmli [20]. Gels were
either directly stained with Coomassie brilliant blue R250 or
subjected to transfer onto nitrocellulose. Tropomyosin bands were
identiﬁed using primary mouse monoclonal anti-tropomyosin anti-
bodies (Sigma, T2780) diluted 1:1000. After washing with TBS-T
buffer (50 mM Tris pH 7.5, 200 mM NaCl, 0.05% Tween 20), the
blots were allowed to react with secondary goat anti-mouse IgG an-
tibodies conjugated to horseradish peroxidase (1:15000) (Jackson
Immunoresearch Laboratories). After three washes with TBS-T and
two washes with TBS (50 mM Tris pH 7.5, 200 mM NaCl) blots
were developed with ECL chemiluminescence kit (Amersham Biosci-
ences) followed by exposure against an X-ray ﬁlm.
3. Results
3.1. Effect of CacyBP/SIP on actin–tropomyosin interactions
It is well established that association of the actin–tropomysin
complex with some actin-binding proteins changes orientation of
tropomyosin on the ﬁlament [21–23]. To examine whether CacyBP/
SIP interferes with actin–tropomyosin interactions, we reconstituted
the ﬁlaments from actin and AEDANS-labeled tropomyosin. Changes
of the AEDANS–tropomyosin ﬂuorescence were monitored as a func-
tion of CacyBP/SIP concentration. Addition of CacyBP/SIP resulted in
an increase in ﬂuorescence intensity by about 10%. The data, normal-
ized as described in Materials and methods, are shown in Fig. 1.
Because ﬂuorescence intensity is sensitive to the density of solution
[24], a control experiment with the use of BSA was performed. BSA
added at molar ratios to actin similar to those of CacyBP/SIP did not
change the ﬂuorescence of AEDANS–tropomyosin (data not shown).
This shows that the observed effect reﬂects real conformational changes
in the actin–tropomyosin ﬁlament induced by CacyBP/SIP.
3.2. Binding of CacyBP/SIP to actin in the presence of tropomyosin
The actinﬁlament is an allosteric and cooperative structure [3], there-
fore changes in the orientation of tropomyosin monitored by AEDANS
ﬂuorescence could be caused by CacyBP/SIP-induced conformational
changes in actin. To verify this possibility, a co-sedimentation assay
was performed. In this assay the actual binding of CacyBP/SIP to the
actin–tropomyosin complex was monitored. In contrast to the curve il-
lustrating changes in AEDANS–tropomyosin ﬂuorescence (Fig. 1), direct
binding of CacyBP/SIP to actin was best ﬁt to a sigmoidal curve (Fig. 2).
Different shapes of the curves shown in Figs. 1 and 2 suggest that the
change in AEDANS–tropomyosin ﬂuorescence did not arise simply as a
result of CacyBP/SIP–actin interaction.
3.3. Binding of CacyBP/SIP to tropomyosin
The increase in the AEDANS–tropomyosin ﬂuorescence evoked by
CacyBP/SIPmight be a result of direct CacyBP/SIP–tropomyosin interac-
tions. To verify this possibility, we used the afﬁnity chromatography
method with CacyBP/SIP coupled to CNBr-Sepharose. Tropomyosin
was applied to the resin in a buffer containing 150 mM NaCl and after
extensive washing was eluted in the same buffer but containing
500 mM NaCl (Fig. 3A). This result suggests that tropomyosin can
Fig. 1. Changes in AEDANS–tropomyosin ﬂuorescence intensity induced by binding of
CacyBP/SIP to the thin ﬁlament. CacyBP/SIP was added at increasing concentrations
(1–24 μM) to 3.0 μM F-actin and 0.4 μM AEDANS–tropomyosin in F-buffer (150 mM
NaCl, 2 mM MgCl2, 20 mM Tris–HCl, pH 7.0). The ﬂuorescence was recorded at
495 nm after excitation at 340 nm. The experimental values were normalized as
described in Materials and methods. The data were collected from four independent
experiments. The curve was drawn by ﬁtting the normalized points to the
ligand-binding equation using the DataWnd software.
Fig. 3. Interaction of tropomyosin with CacyBP/SIP. A) Western blot developed with
anti-tropomyosin antibody showing the binding of puriﬁed tropomyosin to CacyBP/SIP
coupled to CNBr-Sepharose. Lane 1, input; lanes 2 and 3, unbound fraction and last
wash with buffer containing 150 mM NaCl, respectively; lanes 4 and 5, elution and last
wash with buffer containing 500 mM NaCl, respectively. B) Chemical cross-linking of
CacyBP/SIP with tropomyosin analyzed by SDS-PAGE stained with Coomassie brilliant
blue R250. Lanes 2 and 5, CacyBP/SIP alone; lanes 3 and 6, mixture of CacyBP/SIP and
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tropomyosin was also examined by chemical cross-linking of both pro-
teins using EDC. After cross-linking the proteins were separated by
SDS-PAGE and stained with Coomassie brilliant blue. As it is shown in
Fig. 3B, a 65-kDa cross-linking product has been formed (not present
in control sample without EDC), suggesting a direct interaction
between CacyBP/SIP and tropomyosin.
To establish the dissociation constant (Kd) of the CacyBP/SIP–
tropomyosin complex we applied the QCM-D technique. The CacyBP/
SIP protein was considered as a receptor therefore it was immobilized
on the surface of the quartz crystal sensor whereas tropomyosin
(ligand) was dissolved in the buffer. Calculations based on data
obtained in three independent experiments yielded a Kd value of
0.189±0.024×10−6 M (mean±SD). This value is comparable with
the Kd of the CacyBP/SIP–actin complex [7].
Furthermore, double immunostaining with anti-CacyBP/SIP and
anti-tropomyosin antibodies performed on C2C12 cells showed
co-localization of CacyBP/SIP and tropomyosin in both undifferentiatedFig. 2. CacyBP/SIP binding to F-actin–AEDANS–tropomyosin complex observed in the
co-sedimentation assay. Conditions were the same as those used in the ﬂuorescence
assay (see the legend of Fig. 1). The experimental values were normalized as described
in Materials and methods. The points represent collected data from four independent
experiments. The binding curve was obtained by ﬁtting the normalized points to the
Hill equation using SigmaPlot.
tropomyosin; lanes 4 and 7, tropomyosin alone. Proteins were incubated with EDC
(lanes 2–4) and without this agent (lanes 5–7). Lane 1 shows the position of molecular
weight standards (broad range, Biorad). “+” indicates the tropomyosin-CacyBP/SIP
cross-linking product; “⁎”indicates the CacyBP/SIP dimer. A representative experiment,
out of three performed, is shown. C) Co-localization of CacyBP/SIP and tropomyosin in
C2C12 cells. Double immunoﬂuorescence staining for CacyBP/SIP (green) and tropomyo-
sin (red) of the undifferentiated myoblasts (upper panels) and differentiated myotubes
(lower panels) is seen. The yellow color in merges indicates that CacyBP/SIP co-localizes
with tropomyosin. The analysis was done using a confocal microscope (Leica). The scale
bar is 20 μm.myoblasts and differentiated myotubes (Fig. 3C), raising the possibility
of interaction between the examined proteins in these cells.3.4. Effects of CacyBP/SIP on actin ﬁlament organization and function
The inﬂuence of CacyBP/SIP on the organization of actin ﬁlament
was also examined by electron microscopy (Fig. 4). The images
obtained for F-actin alone (Fig. 4A) and in the presence of CacyBP/SIP
added at 5-molar excess over actin (Fig. 4B) show that CacyBP/SIP
alone severed/depolymerized individual ﬁlaments (ﬁlled arrow) as
well as induced the formation of ﬁlament bundles (empty arrow). As
it was expected, tropomyosin alone stabilized the ﬁlaments (Fig. 4C)
and protected them from CacyBP/SIP-induced severing (Fig. 4D).
Fig. 4. CacyBP/SIP affects thin ﬁlament organization. Electron microscopy images of F-actin alone (A), F-actin with CacyBP/SIP (B), F-actin with tropomyosin (C) and F-actin with
tropomyosin and CacyBP/SIP (D). A representative image, out of three performed in each case, is shown. Filled arrows show actin ﬁlaments while the empty arrows — ﬁlament
bundles. Bar=200 μm.
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in the presence of tropomyosin (Fig. 4D).
To conﬁrm the simultaneous interaction between actin, tropomy-
osin and CacyBP/SIP a co-sedimentation assay was performed. As it is
shown in Fig. 5A, all three proteins were present in the pellet indicat-
ing that CacyBP/SIP did not compete with tropomyosin for the bind-
ing sites on actin. Moreover, saturation of the actin ﬁlament with
CacyBP/SIP was not affected by tropomyosin, conﬁrming independent
interactions of both proteins with F-actin (Fig. 5B).
Because the major role of actin ﬁlaments is to support movement
through interaction with myosin motors and activation of the myosin
ATPase, the effects of CacyBP/SIP on the actin-activated myosin S1
ATPase were analyzed. The measurements were done at constant con-
centrations of F-actin (or F-actin–tropomyosin) and myosin S1, and at
increasing concentrations of CacyBP/SIP. At each experimental point
the basal ATPase activity observed in the presence of CacyBP/SIP alone
was subtracted. As shown in Fig. 6, increasing concentrations of
CacyBP/SIP inhibited the actin-activated S1 ATPase (black bars). Tropo-
myosin alone reduced the ATPase by about 40% (the ﬁrst pair of bars).
When CacyBP/SIP was added, an additional decrease by about 20%
was observed (gray bars). Interestingly, in the presence of tropomyosin
much lower CacyBP/SIP concentrations were required to obtain maxi-
mal inhibition than in the absence of tropomyosin. The observed effect
was speciﬁc since the Sgt1 protein, a homolog of CacyBP/SIP, had no
effect on the actin-activated myosin S1 ATP activity (data not shown).Fig. 5. A) Binding of CacyBP/SIP (0 μM— lane 1, 5 μM— lane 2, 8 μM— lane 3) to F-actin
saturated with tropomyosin. B) Binding of CacyBP/SIP at 6 μM or 9 μM to F-actin alone
(lanes 1 and 2, respectively) and to F-actin saturatedwith tropomyosin (lanes 3 and 4, re-
spectively). In A and B the concentrations of actin and tropomyosin were 3 μM and
0.4 μM, respectively. The gels show the protein content of pellets obtained after ultracen-
trifugation. A representative experiment, out of three performed, is shown.Thus, it seems that CacyBP/SIP inhibits myosin S1 ATP activity and
that tropomyosin enhances this effect.
4. Discussion
CacyBP/SIPwas originally discovered as a ligand of S100A6 (calcyclin)
[4] and then as a binding partner of Siah-1 [5]. Later, it appeared that
CacyBP/SIP interacted with some other proteins such as tubulin and
actin and that it might be involved in cytoskeletal rearrangement
[7,8]. In the present work, we focused on CacyBP/SIP-induced
changes in actin ﬁlaments. Since the majority of these ﬁlaments are
associated with tropomyosin, we studied the relationship between
CacyBP/SIP, actin and tropomyosin. An increase in the ﬂuorescence
intensity of AEDANS-labeled tropomyosin upon CacyBP/SIP binding
suggested that the orientation of tropomyosin on the actin ﬁlament
was altered either through allosteric, conformational changes in
actin or by direct interactions of CacyBP/SIP with tropomyosin. The
effect of CacyBP/SIP on the structure and function of actin ﬁlaments
was then conﬁrmed by electron microscopy and by the ATPase assay.
In our earlier paper we have shown that binding of CacyBP/SIP to
actin affects ﬁlament organization [7]. The data obtained and presented
herein have shown that there is interplay between CacyBP/SIP and
tropomyosin in the regulation of the actin ﬁlament and that CacyBP/
SIP may function as a modulator of this ﬁlament. According to the
models of the actin ﬁlament regulation, tropomyosin acts as a steric/
allosteric regulator, which controls access of actin binding proteinsFig. 6. The effect of CacyBP/SIP on actin-activated myosin S1 ATPase activity. The activity
was assayed in the absence (black bars) or presence (gray bars) of tropomyosin. Concen-
trations of CacyBP/SIP are given in the abscissa. The ATPase activities shown in the ordi-
nate were normalized to the activity obtained in the presence of actin alone. The data
were averaged from four independent experiments±SE. The initial value of acto-S1 activ-
ity (no tropomyosin) was 98±12 nmol Pi/min/mg S1.
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the orientation of tropomyosin chains on actin [21]. Increase in the
ﬂuorescence of AEDANS–tropomyosin suggested that the ﬂuorophore
was shifted to a more hydrophobic environment. Conformational
changes within the ﬁlament induced by CacyBP/SIP, could affect the
orientation of tropomyosin allosterically causing a shift in the position
of the ﬂuorescent probe. This supposition was supported by the fact
that signiﬁcant changes in AEDANS–tropomyosin ﬂuorescence were
recorded at low CacyBP/SIP to F-actin molar ratios. This suggests coop-
erative effects of CacyBP/SIP on the tropomyosin–actin interaction.
Since AEDANS is attached to a single cysteine residue, Cys190,
changes in the ﬂuorescence might also be due to direct binding of
CacyBP/SIP to the ﬁlament in the close vicinity of the ﬂuorophore. In
this workwe have shown that CacyBP/SIP binds directly to tropomyosin,
therefore this interaction might either shield the AEDANS probe or facil-
itate a shift of tropomyosin on the actin ﬁlament. It is well documented
that proteins such as troponin [22] or caldesmon [23] determine the po-
sition of tropomyosin on the ﬁlament. CacyBP/SIP seems to belong to this
group of tropomyosin-binding proteins although the exact binding
site(s) of CacyBP/SIP on tropomyosin is unknown.
Our data indicate that CacyBP/SIP does not compete with tropo-
myosin for the binding sites on actin. Moreover, tropomyosin does
not facilitate binding of CacyBP/SIP to actin ﬁlament in contrast to
other actin-binding proteins such as troponin and caldesmon
[reviewed in 25]. As revealed by electron microscopy, CacyBP/SIP ex-
hibits severing and/or depolymerizing activity. Tropomyosin protects
the ﬁlament from these CacyBP/SIP-induced changes similarly to the
protection against severing/depolymerizing activities of ADF/coﬁlin
[26], gelsolin [27] or DNase I [28,29].
Interestingly, the function of CacyBP/SIP was not limited to the actin
ﬁlament organization. Analysis of the regulation of actin-activated my-
osin ATPase revealed inhibitory activity of CacyBP/SIP. In the absence of
tropomyosin, saturation of the actin ﬁlament with CacyBP/SIP reduced
the ATPase activity. In the presence of tropomyosin, themaximal inhibi-
tion took place at lower CacyBP/SIP concentrations, showing that tropo-
myosin enhanced the inhibitory effect. Thus, our data strongly suggest
that CacyBP/SIP and tropomyosin cooperate in the inhibition of actin–
myosin interactions. Although the exact mechanism of the CacyBP/
SIP-dependent regulation remains unclear, one can suppose that bind-
ing of CacyBP/SIP to the ﬁlament arrests tropomyosin in a blocking po-
sition. A similar enhancement of the actin-activated myosin ATPase
activity inhibition in the presence of tropomyosin was shown for
caldesmon [30]. However, it cannot be excluded that the observed inhi-
bition results from actin ﬁlament bundling as it was observed for
amebin [31].
As it was described before, CacyBP/SIP has several binding partners
[6]. Data presented in this work show that tropomyosin is yet another
CacyBP/SIP protein ligand. These numerous interactions, which are pos-
sible due to the high ﬂexibility and multi-domain structure of CacyBP/
SIP [32], might be responsible for an array of cellular functions. Since
most of them are related to the microtubule and actin ﬁlament organi-
zation, CacyBP/SIP can be considered as an important modulator of the
cytoskeleton dynamics.
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